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Abstract 
Background: Aichivirus as a new member of Picornaviridae family was detected and isolated in Japan. 
Aichivirus species, which belongs to genus Kobuvirus, include of three genotypes A, B and C. Based on 
previous reports to detect aichiviruses in stool samples as well as environmental samples such as river waters 
and sewage waters, it has been demonstrated that Aichivirus infect humans by fecal-oral routs. In order to 
establish an examination for the prevalence of Aichivirus among pediatric patients involved to acute 
gastroenteritis, we conducted a RT-qPCR assay for detection and quantification of Aichivirus in collected stool 
samples. 
Materials and Methods: In this study, a total of 160 stool samples from September 2018 to May 2019 were 
collected from presenting pediatric patients with acute gastroenteritis in Karaj hospital, Iran. After viral RNA 
extraction, the RT-PCR was performed to amplify the 3CD junction region of Aichivirus. 
Results: Out of the 160 samples tested, the Aichivirus genomic RNA was detected in 13/160 (8.1%) of stool 
samples. The maximum viral prevalence rate was related to December (30.7%). The co-infection of 
Aichivirus with Salivirus and Saffold virus also assessed, among which high double or triple mixed-
infections were determined. 
Conclusion: This is the first documentation of Aichivirus detection in stool samples that demonstrates 
Aichivirus has been circulating among Iranian pediatric patients. Our results indicate that Aichivirus in 
association with Salivirus and Saffold virus may be considered as a causative agent of acute gastroenteritis. 
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Introduction 
Most commonly diarrheic viruses including 
Rotaviruses, Noroviruses, Astroviruses, and enteric 
Adenoviruses have been related to acute 
gastroenteritis1. However, there are many unknown 
etiological agents of causative viral diarrheal cases, 
which remain to be demonstrated2. Conducting of 
several studies for detection of new emerging enteric 
viruses have recently applied to detect new discovered 
viruses from Picornaviridae family among which 
human Aichivirus was firstly identified by Yamashita 
et al from a patient as a possibly agent for nonbacterial 
oyster-associated gastroenteritis in Japan in 19894. Up 
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to now, Aichiviruses (AiV) have been isolated from 
patients with acute gastroenteritis after consumption 
of polluted see-foods and from contaminated water 
sources consisting river, ground, and sewage waters5. 
Through nucleotide sequence analysis of Aichivirus 
genome, Aichivirus was included in Picornaviridae 
family as a separate genus named Kobuvirus6. 
Aichivirus particles are determined as a small-round 
naked virus with one positive-sense segment of viral 
genomic RNA5,6. The length of Aichivirus genomic 
RNA is 8251 nucleotides with an open reading frame 
encoding 2432 amino acids polyprotein. In general, 
Aichivirus genomic RNA encodes viral leader 
protein, viral structural proteins (VP0, VP3, and 
VP1) and viral nonstructural proteins (2A, 2B, 2C, 
3A, 3B. 3C, and 3D)6,7. Three genotypes consisting 
genotype A, B, and C by analysis of nucleotide 
sequence of human Aichivirus isolates were 
determined, which geographical distribution of 
Aichivirus genotypes is slightly different. Genotype 
A has been identified in Japan and Europe, but 
genotype B has been found in Brazil and other 
countries in Asia other than Japan and genotype C 
has been circulating in Africa5,8. After detection of 
human Aichivirus, bovine Kubovirus species and 
porcine kubovirus species as other members of 
Kobuvirus species have also characterized which 
infect animals5,8. Since mixed-infection of Aichivirus 
with potential pathogenic enteric viruses and bacteria 
has been shown, the clinical importance of 
Aichivirus infections as a causative agent of acute 
gastroenteritis in sporadic and epidemic cases is 
rather unclear3,10. On the other hand, detection of 
Aichivirus without presence of other pathogens in 
conducted studies in Japan, Brazil, Hungry, and 
China have justified that Aichivirus can be induce 
acute gastroenteritis10,15-17. Based on high detection 
rate of antibody against Aichivirus (80-99%) and low 
incidence rate of Aichivirus infections (0.4-
6.5%)8,15,18-23, it suggests that Aichivirus infections 
occur asymptomatically. However, in symptomatic 
cases the clinical signs are defined as fever, diarrhea, 
abdominal pain, nausea, and vomiting4,24.  
Since Aichivirus culture is time-consuming, 
molecular detection Aichivirus based on reverse 
transcription-polymerase chain reaction (RT-PCR) 
and RT-qPCR have been determined as gold standard 
for detection of Aichiviruses5,22,25-27. In this study, we 
examined stool specimens of pediatric patients with 
acute gastroenteritis presenting to Karaj hospital in 
Iran for detection of Aichivirus by RT-PCR assay. 
This is first report of Aichivirus occurrence among 
involved children with acute gastroenteritis in Iran. 
Methods 
Specimens: In order to conduct a retrospective study 
during 9-month period from September 2018 to March 
2019 for assessment of Aichivirus occurrence, a total 
of 160 fecal specimens were collected from walk-in 
clinics. All fecal samples were obtained from a 
hospital in the city of Karaj from pediatric patients 
under 12 years of age that presented with acute 
gastroenteritis. According to age, the pediatric patients 
were divided into under 1 year of age, 1-5 years of 
age, and 6-12 years of age with frequency of 58 
(36.2%), 54 (33.7%), and 48 (30%), respectively. The 
samples were examined to be negative for pathogenic 
bacteria such as Escherichia coli, Salmonella spp, 
Campylobacter, and Shigella ssp. The study was 
reviewed and approved by the ethical committee for 
human experimentation in Faculty of Medicine, Karaj 
University (IR.IAU.K.REC.1398.045). In order to 
preparation of stool specimens, 10% phosphate-
buffered saline (pH 7.2) homogenate of stool samples 
were centrifuged in 8000 ×g for 10 minutes. The 
supernatants were stored in -80°C until RNA 
extraction step. 
Viral RNA extraction and reverse transcription: 
Viral genomic RNA of Aichivirus was extracted from 
300 μL of 10% fecal sample suspensions using the 
Trizol reagent (Invitrogen) according to the 
manufacturer’s protocol. The viral RNA was eluted in 
a final volume of 50 μL. The concentration and quality 
of the extracted RNA were examined by Nanovue 
spectrophotometry (Thermo Fisher Scientific, 
Waltham, MA, USA). The extracted RNA was used 
directly in the reverse transcription reaction or stored 
at −70°C until use. The known positive Aichivirus 
RNA as a control, which was previously documented 
for Aichivirus RNA presence, was also included. 
Briefly, 10 μL of extracted RNA or positive Aichivirus 
RNA was added in RT mixtures (containing random 
primer and dNTPs) and incubated at 80ºC for 10 
minutes and after then placed on ice for 10 minutes. 
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Then, second reaction buffer (containing 10X RTase 
reaction buffer, 0.1 M DTT, HyperScript RTase, and 
RNase inhibitor) was added to the previous mixture 
and incubated at 42ºC for 60 minutes. Finally, the RT 
reaction mixture was incubated at 85ºC for 5 minutes 
to inactivate the enzyme. Nucleotide sequences of the 
partial 3CD region of AiV are highly conserved 
(99.2% to 97%), with amino acid identities of 99 to 
100%, thus the selected previously used primers 
containing forward (5’-
GACTTCCCCGGAGTCGTCGTCT-3’) and reverse 
primers (5’-GCRGAGAATCCRCTCGTRCC-3’)28 
can amplify a 158-bp fragment located between the 
3CD junction region of the Aichivirus genotypes. 
Implementation of the PCR Assay: A PCR reaction 
using forward and reverse primers to detect all of 
AiV genotypes for each sample was performed in a 
20 μL reaction volume containing 2 μL of 
synthesized cDNA as a template, 10 μL master mix 
(BioFact), and 10 mM of each primer. The negative 
and positive control reactions also were included. 
PCR amplification was done with ABI under the 
following program: primary denaturation at 95°C for 
10 minutes, followed by 40 amplification cycles 
consisting denaturation at 95°C for 25 seconds, 
annealing at 60°C for 15 seconds, and extension at 
72°C for 20 seconds. Amplification products were 
analyzed with gel electrophoresis. 
Results 
Aichivirus viral genomic RNA detection in stool 
samples: The RT-PCR assay was implemented for 
detection of AiV in a total of 160 diarrheic stool 
samples collected from Karaj hospital, Iran. Out of 
160 fecal samples tested, 13 (8.1%) were positive for 
AiV. The positive samples showed a 158bp 
amplification product in gel electrophoresis (Figure 1). 
Regarding the characteristics of the 13 patients with 
AiV diagnosed in stool samples, among which four 
samples were related to male and nine samples were 
female, the median age of them was 2.6 years (range 
of 3 months to 12 years). The maximum detection rate 
of AiV was in December with frequency of 30.7% (4 
out of 13) and minimum of AiV detection was related 
to October 7.6% (1 out of 13) and April 7.6% (1 out of 
13). However, AiV Viral genomic RNA was not 
detected in September, November, and May (Table 1). 
Although co-infection of the positive AiV cases with 
other pathogenic viruses such as rotaviruses, 
noroviruses, human adenoviruses, and enteroviruses 
were not assessed, mixed-infection of AiV with other 
newly discovered viruses from picornaviridae family 
including Salivirus and Saffold virus was examined, 
among which 12 samples were also positive for 
Salivirus and 11 samples were also positive for Saffold 
virus (Figure 2). However, co-infections could be as 
triple infection instead of double infection with 
 
Figure 1. Gel electrophoresis for amplified the 3CD junction region of Aichivirus genome. Line 1 is related to DNA marker, lines 2 and 3 
are negative and positive control, respectively, and lines 4 to 6 are related to three positive stool samples in length of 158bp. 
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concomitant infection of Salivirus and Saffold virus 
in one patient. The triple co-infected cases were 
associated with 10 patients (Table 1). 
Confirmation of Aichivirus detection: In order to 
confirm RT-PCR results, sequencing for five positive 
samples were done. The results of sequencing 
showed the highest nucleotide sequence homology to 
3CD sequence of Aichivirus obtained from genebank 
with accession number of AB040749 (Figure 3). 
Discussion 
Human Aichivirus including three genotypes A, B, 
and C are introduced as new emerging viruses 
 
Figure 2. Number of positive stool samples for mixed-infection of Aichivirus with Salivirus and Saffold virus per month from September 
2018 to May 2019. 
 
 
Figure 3. Sequencing results for five sequenced positive stool samples. Sample numbers of selected positive RT-PCR products were 
compared with sequence of Aichivirus with accession number AB040749 gained from NCBI. 
 
Table 1: Characteristics of patients and assessment of co-infections in stool samples by RT-PCR assay. 
Sample number Date of sampling  Sex  Age  Co-infected viruses 
1 October/ 2018 Male  4 Months Salivirus/Saffold virus 
2 December/ 2018 Male  4 Years Salivirus 
3 December/ 2018 Female  2 Years Salivirus 
4 December/ 2018 Female  1 Year Salivirus/Saffold virus 
5 December/ 2019 Male  1 Year Salivirus/Saffold virus 
6 January/ 2019 Male  2 Years Salivirus/Saffold virus 
7 January/ 2019 Male  1 Month Saffold virus 
8 January/ 2019 Female  2 Years Salivirus/Saffold virus 
9 February/ 2019 Female  2 Years Salivirus/Saffold virus 
10 February/ 2019 Male  4 Years Salivirus/Saffold virus 
11 March/ 2019 Male  10 Months Salivirus/Saffold virus 
12 March/ 2019 Male  1 Month Salivirus/Saffold virus 
13 April / 2019 Male  12 Years Salivirus/Saffold virus 
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infecting children and adults during epidemic periods 
and in form of sporadic cases3,8,26. After the first 
detection of Aichivirus in stool sample during an 
outbreak in 1989 in Japan, many studies have been 
identified the different Aichivirus genotypes around 
the world4,8,10-13,18,21,27. However, Aichiviruses have 
also been detected from environmental samples 
containing treated and untreated sewage waters, river 
waters, and ground waters27,29,30. Assessment of 
structural VP1 region and nonstructural 3CD junction 
region of Aichiviruses have been shown to have 
advantage for Aichivirus detection and Aichivirus 
genotyping analysis6,31,32. In the present study, we 
used a set of primers targeting 3CD junction region 
of Aichivirus, which was previously used to identify 
Aichivirus by RT-PCR and RT-qPCR assays27,28. In 
general, previous study, which was conducted by our 
research group, demonstrated using the primers could 
be useful to determine viral detection and 
quantification of Aichivirus in sewage and river 
water samples27. Here, we tested 160 stool samples 
obtained from pediatric patients with acute 
gastroenteritis, which were under 12 years of age and 
were presented to Karaj hospital in Iran. The 
specimens were related to a collection of stools from 
September 2018 to March 2019. From the literature 
search, in contrast of frequent detection rate of 
antibody against Aichivirus (80-99%), the prevalence 
of Aichivirus in both sporadic and outbreak cases 
were estimated to be in range of 0.8-6.5%, which 
have appraised in different countries26,31. The 
prevalence rate of Aichivirus detection in our reports 
was 8.1% for children presenting with acute 
gastroenteritis. This is maximum of reported 
detection rate of Aichivirus at compared with other 
implemented studies in worldwide. Although in this 
study the prevalence of Aichivirus infection in 
pediatric patients less than 12 years of age was 
slightly higher than other studies, conclusion for 
whether Aichivirus is causative agent of 
gastroenteritis in children should be demonstrated 
since we have not used control groups (healthy 
children). With together, we did not test other known 
pathogenic viruses, which account for major agent of 
gastroenteritis in our examined stool samples for 
assessment of double or more co-infection of 
Aichivirus with another viral pathogens. On the other 
hand, we tested the positive samples for detection of 
new emerging viruses including Salivirus and Saffold 
virus which belong to picornaviridae family (data are 
not shown). Out of the 13 positive stool samples for 
Aichivirus, 12 samples were also infected with 
Salivirus, and 11 samples were positive for Saffold 
virus. Generally, mixed-infection in form of triple co-
infection of Aichivirus with Salivirus and Saffold 
virus in one patient were seen. In contrast to Nielson 
and Chuchaona studies12, which had no double 
infection of Aichivirus with Saffold virus, our results 
showed mixed-infection of these viruses in high 
frequency (84.6%). Based on the results, we cannot 
exclude the possibility of effect of mixed-infections of 
these viruses in the induction of gastroenteritis in 
children. Meanwhile, whether double or triple co-
infections of Aichivirus with Salivirus and Saffold 
virus instead of mono-infection can exacerbate the 
severity of gastroenteritis remains to be defined. 
Similar to other studies, which have been, indicated 
the high seasonality distribution of Aichivirus 
infections in December and January, we also detected 
high number of positive samples in cold months12,32. 
Conclusion 
Finally, our results for the first time indicate that 
Aichivirus may be agent of gastroenteritis, which is 
circulating in pediatric patients under 12 years of age 
in Iran. 
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